Phosphorylation of the estrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer

被引：0
|
作者：
Kok, M.
Holm, C.
Michalides, R.
Fles, R.
Koornstra, R. H.
Hauptmann, M.
Neefjes, J.
Stal, O.
Landberg, G.
Linn, S. C.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Lund Univ, Malmo, Sweden
[3] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.11058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11058
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer
    Holm, C.
    Kok, M.
    Michalides, R.
    Fles, R.
    Koornstra, R. H. T.
    Wesseling, J.
    Hauptmann, M.
    Neefjes, J.
    Peterse, J. L.
    Stal, O.
    Landberg, G.
    Linn, S. C.
    [J]. JOURNAL OF PATHOLOGY, 2009, 217 (03): : 372 - 379
  • [2] Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer
    Kastrati, Irida
    Semina, Svetlana
    Gordon, Benjamin
    Smart, Emily
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2019, 483 : 97 - 101
  • [3] Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen
    Chen, Ming
    Cui, Yu-Kun
    Huang, Wen-He
    Man, Kwan
    Zhang, Guo-Jun
    [J]. ONCOLOGY LETTERS, 2013, 6 (01) : 118 - 124
  • [4] Estrogen Receptor α Phosphorylation on Serine 305, p21-Activated Kinase 1 and Tamoxifen Response in Postmenopausal Breast Cancer
    Bostner, J.
    Fornander, T.
    Skoog, L.
    Nordenskjold, B.
    Stal, O.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 596S - 596S
  • [5] Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
    Giordano, Cinzia
    Cui, Yukun
    Barone, Ines
    Ando, Sebastiano
    Mancini, Michael A.
    Berno, Valeria
    Fuqua, Suzanne A. W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 71 - 85
  • [6] Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
    Cinzia Giordano
    Yukun Cui
    Ines Barone
    Sebastiano Ando
    Michael A. Mancini
    Valeria Berno
    Suzanne A. W. Fuqua
    [J]. Breast Cancer Research and Treatment, 2010, 119 : 71 - 85
  • [7] Estrogen Receptor-α Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer
    Kok, Marleen
    Holm-Wigerup, Caroline
    Hauptmann, Michael
    Michalides, Rob
    Stal, Olle
    Linn, Sabine
    Landberg, Goran
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (24) : 1725 - 1729
  • [8] Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer
    Bostner, Josefine
    Skoog, Lambert
    Fornander, Tommy
    Nordenskjold, Bo
    Stal, Olle
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (05) : 1624 - 1633
  • [9] "Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen
    Fowler, Amy M.
    Santen, Richard J.
    Allred, D. Craig
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3413 - 3415
  • [10] Phosphorylation of Estrogen Receptor β at Serine 105 in Primary Breast Cancer
    Hamilton-Burke, W. L. S.
    Shaaban, A. M.
    Cummings, M.
    Holliday, D. L.
    Pollock, S.
    Horgan, K.
    Speirs, V
    [J]. CANCER RESEARCH, 2009, 69 (24) : 754S - 754S
12345